News & Analysis on Clinical Trial Services & Contract Research And Development
BASF AG's Fine Chemicals division is expanding production of pharmaceutical active ingredients with the construction of a new plant at its site in Minden, Germany. A spokesman for the company told In-pharmatechnologist.com that the amount of the...
Drug delivery company Atrix Laboratories confirmed this week that the German regulatory authority, Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), had recently completed a successful inspection of Atrix's manufacturing facility.
New bulk drug manufacturing facilities, worth a total of around €123 million (£90 million), were officially opened this week at AstraZeneca's Avlon Works near Bristol in the UK.